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Sexual Functioning in Breast Cancer Survivors
Heidi M. King
ABSTRACT
Breast cancer diagnosis and treatment has been suggested to effect sexual functioning.
Little is known about how breast cancer patients compare to women without a history of
cancer on measures of sexual functioning, as well as the psychological and physical
factors may contribute to these difficulties. To address these issues, 71 breast cancer
patients and 40 of their nominated friends were recruited and served as participants. All
women received and returned via the mail measures on general background information,
depression, fatigue, marital satisfaction, body image, vaginal symptoms, and sexual
functioning. All the psychological and physical variables assessed correlated with a
measure of overall sexual functioning in the expected directions. With the exception of
the physical variable of vaginal problems (p = .006), where the patient group reported
more problems, the groups did not differ on any remaining physical or psychological
variables. On the overall measure of sexual functioning, no significant differences were
found between the two groups. Additional exploratory analyses in which only women
treated with chemotherapy were compared to the non-cancer participants yield similar
patterns of results. In addition, there was no evidence of interactive effects of age and
breast cancer status on sexual functioning. These results suggest that sexual functioning
in women treated for breast cancer is similar that of a non-cancer comparison with the
exception of more menopausal symptoms. Continued research and interventions towards
addressing menopausal symptoms may lead to even improved sexual functioning among
breast cancer patients.

v

Chapter One
Introduction
Breast cancer is the most common type of cancer diagnosed in women after skin
cancer. According to the American Cancer Society (2005), 211, 240 new cases of breast
cancer will be diagnosed in 2005. The death rate for this same year will be 40,410. The
breast cancer death rate in the 1990s declined by the largest amount in over 65 years.
This sharp decline is due to both improvements in early detection, as well as multi-modal
treatment (e.g., surgery, radiation, chemotherapy, and hormonal therapy). With 97% of
all women diagnosed with early stage breast cancer (Stage I or II) surviving for at least
five years, research is expanding to deal more with side effects and quality of life issues.
Side effects from cancer treatment may include fatigue, nausea, hair loss, compromised
immune function, cognitive impairment, memory problems, depression, and sexual
problems. Although many of these problems abate after the completion of active
treatment, sexual problems appear to persist (Ganz, Schag, Lee, Polinsky, & Tan, 1992;
Ganz et al., 1996; Ganz, 1997).
The present study has two aims. The first aim is to compare sexual functioning of
women diagnosed and treated with early breast cancer to that of a comparison group of
women of a similar age without a cancer history. These women will be compared on the
following components of sexual functioning: interest, desire, arousal, frequency of
orgasm, sexual satisfaction, sexual activity, satisfaction with sexual relationship,
masturbation, and frequency of severe sexual problems. The second aim is to examine
demographic (age, race, educational status), physical (fatigue and vaginal dryness),
psychological (depression and body image), and social factors (marital dissatisfaction)
that may explain individual differences in sexual functioning. This study will compare
the two groups of women, those with a history of breast cancer and those without a
cancer history, on the demographic, physical, psychological, and social factors.
Depending on the results of these analyses, the study may examine potential mediators of
1

differences in sexual functioning between women with and without a history of breast
cancer.
Considerable variability exists in the literature regarding the prevalence of sexual
dysfunction in breast cancer survivors. Fifteen to 37 percent of a sample of 218 women
(Schover et al., 1995) with early stage breast cancer reported sexual dysfunction. In
contrast, Barni and Mondin (1997) reported that 96% of their sample were experiencing
one or more sexual problems.
Ganz et al. (1996) examined the occurrence of sexual functioning problems by
assessing breast cancer survivors at one year post-diagnosis and again either two years
(n=69) or three years post diagnosis (n=70). Women two or three years post-diagnosis
were all experiencing significant worsening in the area of sexual functioning compared to
their year one data (p=0.0001, p=0.0009, respectively). These data suggest that sexual
functioning may deteriorate over time among breast cancer survivors.
Measurement Issues
Inconsistent methodology employed in studies of sexual functioning of breast
cancer survivors may account for the discrepant reports of problems. Kiebert, de Haes,
and van de Velde (1991) summarized some general methodological issues that plague
quality of life research on breast cancer survivors. These issues include inconsistencies
with regard to samples studied (e.g., selection and size), types of treatment, evaluation
points, and assessment tools.
The selection of samples has varied in terms of different inclusion/exclusion
criteria, as well as the means used to recruit survivors. Disease stages included in studies
of sexual functioning include women with stage 0 disease (Ganz et al., 1998) through
stage III disease (Yurek, Farrer, & Andersen, 2000; Gilbar et al., 1997). Also, the sample
sizes across studies have varied from 24 women (Lim, Hoe, Wong, & Soo, 1995) to
1,957 women (Ganz, Desmond, Belin, Meyerowitz, & Rowland, 1999). Next, women
have varied on the types of treatment they received. Currently, a multi-modal approach
to treatment is used including a combination of surgery, chemotherapy, radiation, and
hormonal therapy.
Another variation in studies is the point at which the participant is evaluated. For
example, Schover et al. (1995) collected surveys from 218 women who were anywhere
2

between 0.4 to 9.5 years post surgery. Along with the variability of time at which the
participant is assessed, many studies also lack baseline data or a premorbid assessment of
sexual functioning.
Finally, assessment tools used in studies vary in their format, reliability, and
validity. The assessment of sexual functioning is complicated. A broad range of facets
combine to make-up this construct, and researchers do not always agree on these facets.
Often times, researchers develop their own multiple-choice questions about sexual
functioning (Schover et al., 1995).
Ganz (1997) points out that sexual functioning in women with breast cancer must
be studied in relation to sexual functioning in healthy women. Breast cancer is primarily
a disease of aging women. Sexual functioning naturally declines with age. Therefore, in
order to accurately gauge the effects of breast cancer and its treatment on sexual
functioning, one must compare women with breast cancer to healthy women without a
history of breast cancer. Although several studies have used normative data to interpret
findings regarding sexual functioning (Mortimer et al., 1999; Ganz, Rowland, Desmond,
Meyerowitz, & Wyatt, 1998), no other study was found that included a healthy
comparison group.
Relationship of Demographic Variables to Sexual Functioning
There has been mixed evidence regarding the relationship of age to sexual
functioning difficulties in breast cancer survivors. Schover et al. (1995) examined the
relationship of age to sexual functioning in 218 women who were between 0.4 and 9.5
years post surgery for breast cancer. Women in this study were a mean of 54.2 years old
(SD = 11.8). The authors found that expression of affection and overall sexual
satisfaction did not differ statistically between younger (< 60 years) and older (> 60
years) women. In contrast, frequency of sexual activity (p<0.0001), as well as sexual
desire (p<0.001), was higher among the younger women.
Regarding differences in sexual functioning across ethnic/racial groups, most
samples to date have consisted primarily of Caucasian women. The numbers for minority
women have typically been too small to be analyzed separately. One exception to this
pattern is a study by Ashing-Giwa (1999) that compared quality of life, including sexual
functioning, in 117 African-American women and 161 Caucasian women who were
3

diagnosed with breast cancer and were at least six years post-diagnosis. Results indicated
that the groups did not differ significantly on a sexual functioning subscale. Scores on
the sexual functioning subscale were higher than all other Cancer Rehabilitation and
Evaluation Survey-Short Form (CARES-SF; Schag & Heinrich, 1989) scales suggesting
that sexual functioning was a concern across ethnic groups.
Relationship of Surgical Variables to Sexual Functioning
The emergence of breast conserving surgery as a viable treatment option (Fisher,
et al., 1985) led health care providers to believe that this less mutilating procedure would
result in fewer sexual concerns (Ganz & Coscarelli, 1995). Numerous studies have
sought to evaluate this possibility. Moyer (1997) performed a meta-analysis, based on 23
studies involving 1,860 women of the effects of type of breast cancer surgery on maritalsexual adjustment. The outcome of marital-sexual adjustment reflects the inclusion of
studies that assessed marital satisfaction and/or sexual functioning. The meta-analysis
revealed a small, but statistically significant weighted mean effect size (ES=0.093,
p<0.05). The effect size was in the positive direction indicating that women who had
undergone lumpectomies generally reported better marital-sexual adjustment than women
who had undergone mastectomies.
Relation of Chemotherapy and Endocrine Therapy to Sexual Functioning
Numerous studies have been conducted to examine the impact of chemotherapy
and/or endocrine therapy (tamoxifen) on sexual functioning in breast cancer patients.
The following studies serve as examples of research that examined the sexual effects of
chemotherapy, chemotherapy plus tamoxifen, or tamoxifen.
Schover et al. (1995) looked at the influence of chemotherapy and tamoxifen use
on sexual functioning. When compared to a group of breast cancer survivors treated
without chemotherapy (n=175), women treated with chemotherapy (n=43) were found to
be experiencing significantly greater problems with desire (p=0.032), vaginal lubrication
(p<0.0001), pain (p<0.001), and achieving orgasm during sexual intercourse (p=0.043).
In addition, they reported significantly poorer sexual satisfaction (p=.001) and had sex
less frequently (p=0.013).
In the same study, Schover et al. (1995) found that women who received
tamoxifen (n=44) did not differ significantly from women who did not receive tamoxifen
4

(n=131) on the following sexual variables (after correcting for age and chemotherapy):
frequency, desire, vaginal dryness, pain, ability to reach orgasm during sexual
intercourse, or overall sexual satisfaction.
Ganz et al. (1999) found history of chemotherapy to be a significant predictor of
sexual dysfunction in two independent samples of early stage (0-II) breast cancer
survivors who were between one and five years post-diagnosis (Ganz et al., 1999). The
two independent samples (n=863, n=1094) completed the following sexual functioning
questionnaires: the Breast Cancer Prevention Trial Symptom Checklist (BCPT; Ganz, et
al, 1998), the CARES, the Watts Sexual Functioning Scale (WSFQ; Watts, 1982), and a
one-item satisfaction measure. Use of tamoxifen was not consistently associated with
sexual interest, dysfunction, or satisfaction. However, in the second sample use of
tamoxifen was related to less sexual satisfaction.
Ganz, Rowland, Myerowitz, and Desmond (1998) conducted further research on
the second independent sample (1094 women from Los Angeles and Washington D.C.).
These women had stage 0, I, or II disease and were one to five years post-diagnosis.
They were broken up into the following four groups: no adjuvant therapy (n=265),
tamoxifen (n=356), chemotherapy (n=180), or chemotherapy plus tamoxifen (n=295).
Controlling for age and time since diagnosis, sexual functioning was significantly related
to type of therapy (p = 0.0078). Women who received chemotherapy were more likely to
report pain during intercourse (p=0.0076). Overall, those women receiving
chemotherapy (p=0.0096), as well as women receiving tamoxifen (p=0.034), reported
more problems with sexual functioning than those women who received no adjuvant
therapy.
Relation of Physical Factors to Sexual Functioning
Few studies have investigated the relationship of menopausal symptoms (i.e., hot
flashes, vaginal problems, and urinary problems) to sexual functioning in breast cancer
patients (Ganz et al, 1999; Greendale, Lee, & Arriola, 1999). An intervention study
conducted by Ganz et al. (2000) compared symptomatic breast cancer patients who
received education, skills, medications, and support targeted towards these symptoms (n=
33) to a usual care group (n = 39). Results indicated that both menopausal symptoms (p
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= .0004) and sexual functioning (p = .04) improved for those women involved in the
intervention group relative to those receiving usual care.
Relation of Psychological Factors to Sexual Functioning
Numerous studies (Mock, 1993; Schover, 1995; Ganz et al., 1998; Ganz et al.,
1992) have investigated body image disturbance and depression in breast cancer
survivors. Although both these factors have been well studied in this population, only
body image has been examined in relation to sexual functioning.
Carver et al. (1998) studied concerns about body image and their relationship to
sexual functioning in 66 women with early stage (I or II) breast cancer. Sexual
functioning was measured using items assessing attractiveness, sexual desirability, and
frequency of sexual activity. Results indicated that body image concerns were related to
decreased feelings of sexual desirability. Ganz et al. (1999) tested models for predicting
sexual interest, sexual dysfunction, and sexual satisfaction using two samples of sexually
active breast cancer survivors (n=472 and n=662, respectively) who were between 1.7
and 4.3 years from diagnosis. Body image was measured using the CARES Body Image
Subscale. Body image was found to account for significant variance in the sexual
satisfaction in the first sample, but was not a significant predictor of sexual satisfaction in
the second sample.
Aims
The current study has two aims. The first aim is to determine whether breast
cancer patients experience poorer sexual functioning than women of comparable age with
no history of breast cancer. This was undertaken in order to address a major limitation in
the existing literature. By including appropriate non-cancer comparison group, the nature
and severity of problems in sexual functioning among breast cancer patients would be
better identified.
The second aim is to identify psychological and clinical variables that might
mediate any observed relationship between breast cancer status (positive versus negative
history of breast cancer) and sexual functioning. Variables of interest included
depression, fatigue, marital satisfaction, body image dissatisfaction, and vaginal dryness
as these variables have been shown to differ, or might be expected to differ based on
breast cancer status. As a precondition to examining their role as mediators, it will first
6

be necessary to test hypotheses that these variables: a) are associated with poorer sexual
functioning in the sample as a whole and b) are related to breast cancer status (positive
versus negative history of breast cancer).
Hypotheses
The first set of hypotheses posits that women diagnosed and treated for early
stage breast cancer would report poorer sexual functioning in comparison to a
comparison group of women of a similar age without a history of cancer. Specifically,
women with early stage cancer, when compared to a group of women of a similar age
with no history of cancer, are expected to report:
1A.

Less sexual interest

1B.

Less sexual desire

1C.

Less sexual arousal

1D.

Less frequency of orgasm

1E.

Less sexual satisfaction

1F.

Less sexual activity

1G.

Less satisfaction with sexual relationship

1H.

Less desire to and arousal from masturbation

1I.

More frequent and severe sexual problems.

A second set of hypotheses posits that the following psychological and physical
factors will be associated with poorer overall sexual functioning in the sample as a whole:
2A.

Higher levels of fatigue

2B.

Greater symptoms of depression

2C.

Greater marital dissatisfaction

2D.

Poorer body image

2E.

Greater vaginal dryness

A third set of hypotheses posits that, compared to a comparison group of women
of similar age with no history of cancer, women diagnosed and treated for early stage
breast cancer will report:
3A.

Higher levels of fatigue

3B.

Greater symptoms of depression

3C.

Greater marital dissatisfaction
7

3D.

Poorer body image

3E.

Greater vaginal dryness.

Depending on results of hypothesis testing, exploratory analyses would be
undertaken to determine the extent to which differences in fatigue, depression, marital
satisfaction, body image, and vaginal dryness mediate any discovered relationship
between history of breast cancer and poorer sexual functioning.

8

Chapter 2
Method
Participants
Patients. Breast cancer patients treated at the H. Lee Moffitt Cancer in the past
five years were identified via the Moffitt registry. Information regarding date of
diagnosis, stage, and type of treatment received were obtained from the registry. In
addition to being diagnosed with early stage breast cancer (stage 0, I, or II), these women
met the following eligibility criteria: 1) at least 18 years of age, 2) proficient in English,
3) able to provide informed consent, 4) no psychiatric or medical conditions that would
hinder participation, 5) medical visit in the last year that confirmed no clinical evidence
of breast cancer, 6) at least one year and no more than five years post diagnosis, 7) no
other cancer history (with the exception of basal skin cancer ), and 8) have a spouse or
romantic partner. These women were asked to complete a questionnaire through the mail
inquiring about their level of fatigue, mood, marital satisfaction, body image, and sexual
health. In addition, these women were asked to provide contact information for female
friends within fifteen years of their age who had never been diagnosed with breast cancer
who may be willing to serve as members of a non-cancer comparison sample.
Of the 563 MCC patients who received initial letters about the study, 230 (41%)
were unable to be contacted (see Figure 1). Of the patients contacted, 83 (25%) were
found to be ineligible. From the remaining women contacted 179 (72%) refused thus
leaving 71 (28%) analyzable questionnaires. The mean age of these women was 61 years
(SD = 9.87, range = 39 to 82 years). The majority were Caucasian (96%), married
(93%), had greater than a high school education (80%), were employed outside the home
(56%), had an annual household income greater than $40,000 (72%), and were
postmenopausal (96%) (see Table 1). Medically, the majority of women were diagnosed
with Stage I (41%) and Stage II (45%) disease, were treated surgically with
9

lumpectomies (84%), received radiation treatment only (53%), and were between 3 and 5
years post-diagnosis (83%) (see Table 2).
Non-Cancer Comparison Group. Using peer nomination procedures, a sample of
women without a history of breast cancer was also obtained for the study. In addition to
having no prior cancer diagnoses (with the exception of basal skin cancer), the nominated
group also met the following eligibility criteria: 1) at least 18 years of age, 2) proficient
in English, 3) informed consent, 4) no psychiatric or medical conditions that would
hinder participation, and 5) have a spouse or romantic partner.
Of the 123 women nominated, 22 (18%) were unable to be contacted (see Figure
2). Of those contacted, 18 (18%) were found to be ineligible. From the remaining
women contacted, 34 (41%) refused to participate thereby leaving 49 questionnaires
(59%). Upon determining that the non-cancer comparison group had over-sampled
women in the fifth decade relative to the patient group, an approximate 2-to-1 matching
procedure by decade of age was used that resulted in exclusion of nine women from the
non-cancer comparison group. Thus, the final non-cancer comparison group was
comprised of 40 women. The mean age of these women was 60 years (SD = 9.83, range
39-82). The majority were Caucasian (100%), married (90%), had higher than a high
school education (90%), were not employed outside the home (62%), and had a
household income of greater than $40,000.00 (65%). Eighty percent of the women
reported being postmenopausal (see Table 1).
Procedure
An introductory letter (see Appendix A) was sent to breast cancer patients from
the Moffitt registry selected randomly after stratifying by time since diagnosis and
treatment received. A toll-free number was included in the letter that allowed the
recipient to decline any further information about the study. Breast cancer patients were
then contacted by telephone and read a scripted description (see Appendix B) of the
study, were asked questions to confirm eligibility, and were asked whether they were
willing to provide verbal consent for participation. Upon receiving verbal consent, each
patient received the following materials through the mail: two copies of the written
informed consent, two copies of the HIPPA research form, a questionnaire packet, a peer
nomination form, personalized nomination cards, and a self-addressed stamped envelope.
10

Each participant was asked to return one signed copy of the informed consent and HIPPA
research authorization form, a completed packet, a completed peer nomination form, and
completed personalized nomination cards. The personalized nomination cards had a
preprinted summary of the study on a Moffitt card leaving the salutation and closing
blank so the participant could personalize the card to the person they were nominating.
All nomination cards were returned to the researcher so that they could be tracked.
Initially, breast cancer participants were asked to nominate peers without a history
of breast cancer who were anywhere from five years younger to five years older than
themselves. However, due to difficulties recruiting, the age range was increased on May
19, 2004 to fifteen years younger to fifteen years older than the breast cancer participants.
Women who were nominated received the invitation (see Appendix C)
personalized by the breast cancer patient who nominated her. This card was followed-up
with a phone call and scripted description of the study, interest was established, and
eligibility confirmed. Upon receiving verbal consent, each woman received the
following materials through the mail: two copies of the written informed consent, two
copies of the HIPPA research authorization form, a questionnaire packet, a peer
nomination form, personalized nomination cards, and a self-addressed stamped envelope.
Each participant was asked to return one signed copy of the informed consent and HIPPA
research authorization form, and a completed packet.
Follow-up calls and letters were sent out to women who returned packets with
missing information. Thank you letters were sent out to all participants. If requested, a
pamphlet entitled, Sexuality and Cancer, sponsored by the American Cancer Society
(2001) was provided.
Measures
The survey battery included measures of demographic and clinical information,
along with valid and reliable measures of fatigue, depression, marital satisfaction, body
image, symptom concerns, and sexual functioning. The packet was estimated to take
approximately 25 minutes to complete.
Demographic and Clinical Information. A standardized self-report measure was
used to obtain general demographic and clinical information (see Appendix D and E).
The following demographic information was obtained: age, ethnicity, marital and
11

employment status, income, occupation, and educational level. General medical and
sexual history information was also obtained from all participants. Medical history
included menopausal status, use of hormone replacement therapy, and height and weight.
Sexual history included questions about length of time with current sexual partner, as
well as history of sexual problems for self or partner. Participants with a history of breast
cancer were asked additional questions specific to cancer diagnosis and treatment. The
information obtained included the time since diagnosis, type of surgery, and type of
cancer treatment. In addition to participant self-report, the H. Lee Moffitt Cancer
Registry, as well as the participant’s medical charts were reviewed to obtain relevant
medical history such as date of diagnosis, disease stage, type of cancer treatments, and
history of cancer recurrences.
Depressive Symptomatology. The Center for Epidemiologic Studies, Depression
Scale (CES-D; Radloff, 1977) is a 20-item self-report measure originally developed to
assess current depressive symptomatology in the general population (see Appendix F).
The following six components of depression are measured on 4-point Likert scales
ranging from 1 (rarely or none of the time) to 4 (most or all of the time): depressed
mood, feelings of guilt and worthlessness, feelings of helplessness and hopelessness,
psychomotor retardation, loss of appetite, and sleep disturbance. Participants are asked to
respond to each item based on the degree to which she has been experiencing each
symptom for the past week. Scores range from 0 to 60 with higher scores indicating
more severe depressive symptomatology. The CES-D is a reliable and valid measure.
High internal consistency has been determined with split-half correlations for psychiatric
patient groups (0.85), as well as normal groups (0.77) and with coefficient alphas for
patient groups (0.90) and normal groups (0.85), respectively. Coefficients alphas
calculated in present study for the breast cancer patients (.89) and non-cancer
comparisons (.91) reflect high internal consistency. The CES-D has been shown to be a
valid measure with its correlation to other depression inventories such as the Beck
Depression Inventory (0.81), as well as the Zung Depression Scale (0.90) (Weissman,
Prusoff, & Newberry, 1975). Although validated in many different samples, it has been
specifically shown to be psychometrically sound for assessing depressive symptoms in
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cancer patients (Devins, Orme, Costello, & Binik, 1988; Hann, Winter, & Jacobsen,
1999).
Fatigue Symptomatology. The Fatigue Symptom Inventory (FSI; Hann et al.,
1998) is a 13-item self-report measure of fatigue intensity, duration, and interference with
quality of life in cancer patients (see Appendix G). Regarding fatigue intensity,
respondents indicate on an 11-point scale (0 = not at all fatigued to 10 = maximum
fatigue) their most, least, and average fatigue level in the past week, as well as their
current level of fatigue. Then, seven items keyed to another 11-point scale (0 = no
interference to 10 = extreme interference) are used to assess the level of interference
caused by fatigue in the past week to the following areas: general activity level, ability to
bathe and dress, work activity, ability to concentrate, relations with others, enjoyment of
life, and mood. Finally, two duration items inquire about number of days in the past
week the respondent has felt fatigued (0-7 days) and the percentage of each day that
fatigue was experienced (0 = none of the day to 10 the entire day). The FSI is a reliable
and valid measure. The internal consistency for the 7-item subscale measuring the level
of interference caused by fatigue was above 0.90 for young and old cancer patients with a
variety of cancer diagnoses, as well as healthy individuals (Hann, Denniston, & Baker,
2000). Regarding test-retest reliability, the FSI subscales produced low to moderate
correlations between assessments. Convergent, divergent, and construct validity have all
been demonstrated for the FSI (Hann et al., 1998). The 7-item subscale measuring the
level of interference caused by fatigue was employed in this study with coefficient alphas
for the breast cancer (.93) and non-cancer patient (.95) groups reflecting high internal
consistency.
Body Image. The Body Exposure in Sexual Activities Questionnaire (BESAQ;
Hangen and Cash, 1991) is a 28-item self-report questionnaire designed to assess body
image during sexual activity, or personal ease with physical appearance during differing
degrees of sexual activity (see Appendix H). Specifically, it measures physical selfconsciousness and body exposure avoidance during sexual encounters. Participants are
asked to rate on a 5-point Likert scale (0=never to 4 = always) how representative each
item is of their own thoughts and beliefs during differing degrees of sexual activity.
Items can be calculated into a total score, as well as separated into two subscales: worry
13

and self-consciousness (WSE) and comfort with body exposure (CBE). The measure has
high internal consistency for the scale as a whole (0.98), as well as for both the WSC
(0.97) and CBE subscales (0.92) (Thompson, Heinberg, Altabe, & Tantleff-Dunn, 1999).
The total score was utilized in the present study and coefficient alphas calculated for the
breast cancer patients (.87) and the non-cancer patients (.90) reflect high internal
consistency. In a sample of 145 sexually active college-aged women, lower scores on the
BESAQ (less anxiety or avoidant focus on their bodies) were found to be significantly
(p< .01) correlated with higher sexual functioning scores. The Body-Self Relations
Questionnaire: Appearance Evaluation Subscale (BSRQ—AES) is a subscale of the
Multidimensional Body Self-Relations Questionnaire (MBSRQ; Cash, 1997). The
BSRQ—AES is a 7-item self-report questionnaire designed to assess both satisfaction
and evaluation of the body (see Appendix I). Participants are asked to rate on a 5-point
Likert scale (1= definitely disagree to 5 = definitely agree) how representative each item
is of their own thoughts and beliefs regarding satisfaction and evaluation of the body.
The measure has high internal consistency for the scale as a whole (0.88) (Thompson et
al., 1999). In the present study, coefficient alphas of .90 for the breast cancer patients
and .86 for the non-comparison group reflect high internal consistency. The BRSQ—
AES has been used and has strong set of normative data (Brown, Cash, & Milulka, 1990;
Cash, Ancis, & Strachan, 1997).
Marital Satisfaction. The Dyadic Adjustment Scale (DAS; Spanier, 1976) is a 32item multi-dimensional self-report measure designed to measure the quality of adjustment
in both committed and marital relationships (see Appendix J). Participants rate each item
on a 7-poing Likert scale ranging from “extremely unhappy” to “perfect.” The scale is
split up into the following four subscales: satisfaction, consensus, cohesion, and
affectional expression. The DAS is a reliable and valid measure. The internal
consistency reliability is high, with a range of 0.73 to 0.96 for all four subscales as well
as the total summary score. This study employed the marital satisfaction and affectional
expression subscales. These scales demonstrated adequate to high internal consistency
for the following breast cancer patients (.69 and .81, respectively) and the non-cancer
comparison group (.81 and .77, respectively). Content, criterion-related, and construct
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validity have all been established for the DAS (Busby, Christensen, Crane, & Larson,
1995).
Menopausal Symptoms. The Breast Cancer Prevention Trial (BCPT) Symptom
Checklist (Ganz, Day, Ware et al., 1998) is a 43-item self-report measure of physical and
psychological symptoms associated with menopause as well as tamoxifen use (see
Appendix K).

All symptoms are rated on how bothersome they have been in the past 4

weeks using a 5-point Likert scale (0=not at all to 4=extremely). Seven items make up
three subscales that are specific to menopausal symptoms: hot flash subscale, vaginal
subscale, and urinary symptom subscale. The internal consistency reliability is reported
to be high, with alpha coefficients for each subscale above 0.73. These three subscales
can be added together to create the Symptoms Scale Score, which has been shown to
have an internal consistency reliability of 0.50. The present study utilizes the vaginal
subscale only. The internal consistency reliability is low, demonstrated by coefficient
alphas of .57 for breast cancer patients and .59 for the non-cancer comparison
participants.
Sexual Functioning. The Sexual Function Questionnaire (SFQ; Syrjala et al.,
2000) is a 30-item multi-dimensional, self-report questionnaire designed to measure
sexual functioning in both medically ill and healthy populations (see Appendix L). The
measure is composed of an Overall SFQ Score, two summary scales, Sexual Functioning
and Treatment Impact, as well as the following nine subscales: interest, desire, arousal,
orgasm, satisfaction, activity, relationship, masturbation, and sexual problems.
Respondents answer items based on 6-, 7-, or 11-point Likert scales keyed for the past
month. Approximately 10 minutes are needed to complete this questionnaire. The SFQ
is a reliable and valid measure. The reported internal consistency for the overall SFQ
score for women is high (α = .94), as are the internal reliabilities for all subscales
(ranging from α=0.81 for sexual problems to α = 0.93 for orgasm). For both groups of
women in this study, the internal reliability for the overall SFQ score was high (α = .93)
The internal reliabilities among the subscales are high for breast cancer patients (ranging
from α=0.71 for desire to α = 0.97 for orgasm) and range from adequate to high for noncancer participants (ranging from α=0.65 for interest to α = 0.98 for masturbation).
Content, criterion, and discriminant validity have all been demonstrated for the SFQ
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(Syrjala et al., 2000). Due to researcher error, the problem subscale score was not
obtained. Therefore, the overall sexual functioning score and following eight subscales
were used: interest, relationship, desire, masturbation, activity, orgasm, satisfaction, and
arousal.
Statistical Power
Statistical power was calculated based on the sample size obtained. For between
group differences, with 71 breast cancer patients and 40 non-cancer participants, there
was power of .80 (p<.05, two tailed) to detect an effect size of between .5 and .6 standard
deviation units (d = .55). This corresponds to a medium effect size (Cohen, 1998).
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Chapter Three
Results
Preliminary Analyses
T-tests or chi-square analyses were conducted, as appropriate, to compare the
breast cancer and non-cancer comparison groups on the demographic variables of age,
household income, marital status, education, employment, and ethnicity. Results
revealed a marginally significant difference for employment status (p < .1) (see Table 1).
Since employment status was not significantly correlated with the overall sexual
functioning score on the SFQ (r = -0.12, p = .22), it was not included as a control variable
in subsequent analyses. Additional analyses indicated a significant difference between
groups in menopausal status (p = .008), with breast cancer patients more likely to be
postmenopausal. Since menopausal status is likely to be affected by treatment for breast
cancer, it was not included as a control variable in subsequent analyses.
Group Differences on Sexual Functioning Variables
It was hypothesized that a past diagnosis of breast cancer would be associated
with more frequent and more severe sexual problems as measured by the SFQ overall
score and the nine subscales: interest, desire, arousal, orgasm, satisfaction, masturbation,
activity, satisfaction with sexual relationship, and sexual problems. As noted previously,
due to researcher error, the sexual problems subscale was not collected. Therefore, t-tests
were performed on the overall score and on each of the remaining subscale scores to
determine if significant differences existed between the breast cancer patients and the
non-cancer comparison participants. Contrary to predictions, there were no significant (p
< .05) differences between the two groups on these variables (see Table 3).
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Relationship of Psychological and Physical Variables to Sexual Functioning
It was hypothesized that poorer overall sexual functioning would be associated
with higher levels of fatigue, greater depressive symptomatology, greater marital
dissatisfaction, poorer body image, and greater vaginal dryness. As predicted, each of the
psychological and physical variables was significantly (p < .05) correlated with overall
sexual functioning for the sample as a whole (see Table 4). Specifically, scores on the
CES-D, FSI, BESAQ, and vaginal subscale of the BCPT were all negatively correlated
with overall sexual functioning. The direction of these relationships indicates that, as
expected, worse overall sexual functioning was associated with more severe depressive
symptomatology (CES-D), more disruption from fatigue (FSI), poorer body image
(BESAQ), and more problems with vaginal dryness, genital itching/irritation, and pain
with intercourse (vaginal subscale of BCPT). In addition, scores on the two DAS
subscales of marital satisfaction and affectional expression, as well as on the appearance
evaluation subscale of the BSRQ are all significantly (p < .05) positively correlated with
overall sexual functioning. The direction of these relationships indicates that, as
expected, women who were more satisfied in their marital relationships (DAS marital
satisfaction subscale), who are better able to express themselves emotionally (DAS
affectional expression subscale), and who are satisfied with their physical appearance
(BSRQ-AE) reported better overall sexual functioning.
Group Differences on Psychological and Physical Variables
Finally, it was hypothesized that a past diagnosis of breast cancer would be
associated with higher levels of fatigue (as measured by the FSI), greater symptoms of
depression (as measured by the CES-D), greater marital dissatisfaction (as measured by
the two DAS subscales), less emotional expression (as measured by the DAS), poorer
body image (as measured by the BESAQ and BSRQ-AE), and greater vaginal dryness (as
measured by the vaginal problems subscale of the BCPT). T-tests were performed on
each of these psychological and physical variables to determine if significant differences
existed between the breast cancer patients and the non-cancer comparison participants.
Contrary to predictions, the groups only differed significantly on the vaginal problems
subscale of the BCPT (t = 2.82; p = .006), with the breast cancer patients reporting more
vaginal problems (see Table 5) than the non-cancer comparison participants.
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Additional Analyses
Because conditions for a mediational model were not met, no further analyses in
this vein were conducted. However, additional analyses were pursued. Because of prior
research attesting to the intensity of chemotherapy and its effect on menopausal status
(Ganz et al., 1998), the women who had received chemotherapy alone (n=7) or in
conjunction with radiation (n=26) were combined and evaluated against the non-cancer
comparison participants. T-tests were performed on the overall SFQ score and the eight
subscales to determine if significant differences existed between the breast cancer
patients who had received chemotherapy and the non-cancer comparison participants.
Results mirror the results found for the sample as a whole. Specifically, there were no
significant differences between breast cancer patients treated with chemotherapy and a
non-cancer comparison group on the overall score of sexual functioning on the SFQ or
any of the eight subscales (see Table 6).
Finally, exploratory analyses were conducted to examine whether age might
moderate the relationship between group membership (cancer vs. non-cancer) and sexual
functioning. Previous literature suggests (Schover et al., 1995) that some of the effects of
cancer and its treatment might be more evident among younger women. Toward this
end, separate hierarchical multiple regression analyses were performed on the overall
SFQ score and each of the eight subscales. In each analysis, age and group membership
were entered on the first step followed by the interaction of age and group membership
on the second step. Of particular interest was whether the interaction term accounted for
additional significant variability in sexual functioning. The interaction between age and
breast cancer status did not account for a significant amount of variance (p < .05) in the
overall SFQ score or on any of the eight subscales scores (see Table 7).
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Chapter Four
Discussion
A goal of the present study was to determine whether sexual functioning was
poorer in breast cancer survivors than women with no history of cancer. In addition, the
psychological and physical variables of depression, fatigue, marital satisfaction, body
image, and vaginal problems were investigated as potential mediators of the hypothesized
relationship between a history of breast cancer and sexual functioning. This discussion
will review the findings, consider the limitations of the current study, and discuss clinical
implications and future research directions.
Contrary to predictions, women who completed treatment for breast cancer within
the past five years did not report higher levels of sexual dysfunction when compared to
women with no history of breast cancer. These groups of women did not differ
significantly on an overall measure of sexual function or on any of the eight individual
subscales examining the sexual phases. The variables of depression, fatigue, marital
satisfaction, body image, and vaginal problems did correlate with sexual functioning in
the predicted directions for this sample as a whole. Specifically, as scores on the scales
of depression, fatigue, body dissatisfaction, and vaginal problems increased, scores on a
measure of sexual functioning decreased. Likewise, as scores on measures of marital
satisfaction and body satisfaction increased, scores on a measure of sexual functioning
increased. However, when the breast cancer patients and the non-cancer comparison
participants were compared on these psychological and physical variables, they differed
significantly only on reported number of vaginal concerns. The lack of significant
differences on these variables based on breast cancer status was contrary to initial
hypotheses.
Based on previous research suggesting that treatment with chemotherapy may
have a more damaging effect on women’s sexual functioning (Schover et al., 1995), we
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preformed additional analyses comparing only women treated with chemotherapy to the
non-cancer comparison group. This new grouping based on treatment received yielded
similar non-significant results. Finally, analyses were performed to look at the potential
interactive effects of age and breast cancer status on sexual functioning. This interaction
was not found to contribute significantly to differences in sexual functioning.
At first glance, these results do not appear to fit neatly into the current body of
literature that posits a prevalence of sexual dysfunction in breast cancer survivors of
anywhere from 15-37% (Schover et al., 1997) to 96% (Barni & Mondin, 1997).
However, the current literature has known problems with sample selection and make-up
(Ganz et al., 1998; Yurek et al., 2000; Gilbar et al., 1997), as well as measurement
variability (Kiebert, et al., 1991). Specifically, measurements of sexual functioning used
often vary in their format, reliability, and validity oftentimes with researchers developing
their own measures of sexual functioning.
The current study did find evidence that vaginal problems were more common in
cancer survivors. This result may reflect the effects of tamoxifen that many of the
women were receiving, as well as the high percentage (96%) of postmenopausal women.
Most breast cancer patients are postmenopausal due to age at diagnosis or treatment
effects (Ganz et al., 2000). These vaginal problems included vaginal dryness, genital
itching/irritation, and pain with intercourse. While difficulties with menopausal
symptoms are not exclusive to breast cancer patients they may be intensified to due to
tamoxifen use and effects of chemotherapy. Previous research has shown that
menopausal symptoms and sexual functioning can be improved with proper symptom
assessment, education, counseling, and pharmacologic and behavioral interventions
(Ganz et al., 2000).
Limitations
This study has several limitations that need to be addressed. The samples for the
current study consisted primarily of Caucasian, well-educated, higher income women.
This feature may limit the generalizability of the findings to populations more diverse
with regard to race/ethnicity, education, and socioeconomic status. The relatively low
response rate of 28% for breast cancer patients and 59% for non-cancer comparisons is
another major limitation. A systematic bias may have existed connected with whether or
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not a woman agreed to participate. For example, it is possible that women with more
severe problems in sexual functioning may have declined to participate. The use of
cross-sectional design that includes a sample of patients with considerably varied time
since diagnosis is another limitation. This feature limits the ability to make conclusions
about the time course of problems in sexual functioning. Statistical power is yet another
limitation. Although the sample size had power adequate to detect a medium effect,
sexual functioning may have been a smaller than medium effect. Finally, all data was
collected via self-report without any corroborating objective measures of sexual
functioning. Ideally, corresponding data would also have been collecting from spouses
and partners.
Future Directions
Whenever possible, future research should strive to include a non-patient
comparison group in order to identify any needs that set cancer patients apart from those
with no cancer history. Longitudinal research employing pre-treatment baseline
assessments, as well as larger and more demographically diverse samples would allow
for a better understanding of sexual functioning over time, as well as any potential
cultural and demographic differences. Comparison studies between cancer patients by
age of diagnosis, disease stage, and treatment type also may shed light on how these
medical variables affect sexual functioning outcomes. In addition, new procedures
should be employed to increase participation. With the use of websites and e-mails
versus telephone and mail, faster and more efficient recruitment may be possible.
The number of breast cancer patients who did report vaginal problems warrants
more intervention studies. The Ganz et al. (2000) intervention study was able to reduce
menopausal symptoms and improve sexual functioning. Future research should seek to
continue to study interventions that could better educate, inform, and normalize this
experience for breast cancer survivors.
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Table 1
Demographic Characteristics of Breast Cancer Patients and Non-Cancer Comparison
Participants

Breast Cancer Patients

Non-Cancer
Participants

N

N

(%)

(%)

Race
White
Non-White

68
3

(96%)
(4%)

40
0

χ2

p

1.74

.18

.30

.58

1.78

.18

3.63

.06*

2.2

.33

7.13

.008**

(100%)
(0%)

Marital Status
Married
Not Married

66
5

(93%)
( 7%)

36
4

(90%)
(10%)

Education
< 12 years
> 12 years

14
57

(20%)
(80%)

4
36

(10%)
(90%)

Employment
Employed
Not employed

40
31

(56%)
(44%)

15
25

(38%)
(62%)

Household Income
< $40,000
> $40,000
Did not answer

10
51
10

(14%)
(72%)
(14%)

4
26
10

(10%)
(65%)
(25%)

Menopausal Status
Pre- or
perimenopausal
Postmenopausal

3

(4%)

8

(20%)

68

(96%)

32

(80%)

*p < .1
**p < .05

23

Table 2
Medical Characteristics of Breast Cancer Patients (N = 71)

N

(%)

Stage
0
I
II

10
29
32

14%
41%
45%

59
10
1
1

84%
14%
1%
1%

63
4
4

88%
6%
6%

7
26
38

10%
37%
53%

2
10
30
29

3%
14%
42%
41%

Surgery Type
Lumpectomy
Mastectomy
Bilateral Lumpectomy
Bilateral Mastectomy
Reconstructive Surgery
None
Immediate
Delayed
Treatment Received
Chemo only
Chemo and XRT
XRT only
Time Since Diagnosis
1 - 2 years
2 – 3 years
3 – 4 years
4 – 5 years
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Table 3
Comparison Between Breast Cancer Patients and Non-Cancer Participants on Sexual
Functioning Questionnaire

Breast Cancer Patients
SFQ
M (SD)

Non-Cancer
Participants
SFQ
M (SD)

t

p

Overall Score

2.41 (0.88)

2.50 (0.89)

-0.47

.64

Interest Subscale

1.50 (1.05)

1.49 (0.87)

0.05

.96

Desire Subscale

2.80 (1.21)

2.84 (1.43)

-0.17

.86

Arousal Subscale

1.77 (1.19)

1.69 (1.14)

0.33

.74

Orgasm Subscale

3.39 (1.68)

3.80 (1.68)

-1.24

.22

Satisfaction Subscale

3.04 (1.68)

3.44 (1.83)

-1.18

.24

Activity Subscale

2.63 (1.46)

2.60 (1.34)

0.10

.92

Relationship Subscale

3.07 (1.08)

3.24 (1.11)

-0.78

.44

Masturbation Subscale

0.62 (0.99)

0.57 (1.02)

0.26

.80
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Table 4
Correlational Analyses of Psychological and Physical Variables with Sexual Functioning
Questionnaire (SFQ) Overall Score

SFQ
Overall
Score
Depressive Symptomatology (CES-D)

-0.31**

Fatigue (FSI)

-0.23*

Marital Satisfaction (DAS Marital Satisfaction Subscale)
0.56***
Emotional Expression (DAS Affectional Expression Subscale)
0.44***
Body Image (BESAQ)

-0.41***

Body Image (BSRQ)

0.26*

Vaginal Problems (BCPT Vaginal Subscale)

-0.24*

* p<.05
**p<.001
***p<.0001
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Table5
Comparison Between Breast Cancer Patients and Non-Cancer Participants on
Psychological and Physical Variable Scores

Breast Cancer Patients
M (SD)

Non-Cancer
Participants
M (SD)

t

p

CES-D (depression)

9.23 (8.78)

6.73 (7.94)

1.90

.06

FSI (fatigue)

1.41 (1.67)

1.37 (1.88)

0.12

.91

DAS—Marital
Satisfaction Subscale

8.60 (2.20)

8.62 (2.84)

-0.09

.93

DAS—Affectional
Expression Subscale

38.42 (5.15)

38.19 (4.84)

0.23

.82

BESQ (body image)

36.11 (21.53)

34.92 (21.15)

0.26

.80

BSRQ (body image)

2.23 (0.95)

2.41 (0.73)

-1.03

.31

BCPT—Vaginal
Subscale

3.69 (2.65)

2.21 (2.53)

2.82

.0057*

27

Table 6
Comparison Between Breast Cancer Patients Treated with Chemotherapy and NonCancer Comparison Participants on Sexual Functioning Questionnaire

Breast Cancer Patients
SFQ
M (SD)

Non-Cancer
Participants
SFQ
M (SD)

t

p

Overall Score

2.17 (0.90)

2.50 (0.89)

-1.50

.14

Interest Subscale

1.47 (1.05)

1.49 (0.87)

- 0.08

.94

Desire Subscale

2.57 (1.26)

2.84 (1.43)

-0.87

.39

Arousal Subscale

1.58 (1.05)

1.69 (1.14)

-0.44

.66

Orgasm Subscale

3.10 (1.68)

3.80 (1.68)

-1.75

.08

Satisfaction Subscale

2.69 (1.64)

3.44 (1.83)

-1.84

.07

Activity Subscale

2.40 (1.51)

2.60 (1.34)

- 0.62

.54

Relationship Subscale

2.90 (1.12)

3.24 (1.11)

-1.27

.21

Masturbation Subscale

0.65 (0.95)

0.57 (1.02)

0.34

.74
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Table 7
Significance of Interaction of Age and Group Membership for Each Scale of the SFQ

β

F

p

Overall Score

-.72

1.11

.30

Interest Subscale

-.57

.77

.38

Desire Subscale

-.87

1.86

.18

Arousal Subscale

-.37

.33

.57

Orgasm Subscale

.33

.27

.60

Satisfaction Subscale

-.07

.01

.92

Activity Subscale

-.22

.12

.73

Relationship Subscale

-.53

.66

.42

Masturbation Subscale

-.37

.33

.57
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Figure 1. Flow chart of recruitment for breast cancer patients
230 unable to be contacted
•
•

563
introductory
letters sent

333 contacted

211 Not answered
19 Disconnected
83 ineligible
•
•
•
•
•
•
•
•
•

49 No partner
13 Dx date out of range
5 Other cancer dx
5 Recurrence
3 Stage III disease
3 Language Barrier
2 No annual oncologist visit
2 Deceased
1 Other medical problems

250 contacted
and eligible
179 refused to participate
•
•
•
•

•
•
•
•
•
•

57 Called decline line
57 Verbally agreed but failed to
return packet
17 Not interested
17 Declined after receiving packet
o 9 Uncomfortable with subject
o 3 Not interested
o 2 Uncomfortable with consent
o 2 Sick spouse
o 1 Time
10 Uncomfortable with subject
9 No time
5 Ill (non-cancer related)
3 Hate paperwork
3 Caretaking
1 Avoiding talking about cancer
30

71
questionnaires
analyzed

Figure 2. Flow chart of recruitment for non-cancer participants

22 unable to be contacted
•
•

19 Not answered
3 Wrong contact info

123 women
nominated

101 contacted

18 ineligible
•
•
•

10 No partner
7 Cancer history
1 Deceased

83 contacted
and eligible

49 eligible
questionnaires
returned

34 refused to participate
•
•
•
•

16 Verbally agreed but failed to
return packet
9 Not interested
5 Uncomfortable with subject matter
4 No time

9
questionnaires
deleted for
procedural
purposes

40
questionnaires
analyzed
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Appendix A: Introductory Letter for Breast Cancer Patients

To Our Patients,
As part of our continuing efforts to improve patient care, we are asking selected patients
treated by the Breast Program at Moffitt Cancer Center and their friends to participate in
a research study. This study is being conducted in collaboration with Heidi Grenke, B.A.
and Paul Jacobsen, Ph.D. from Moffitt’s Psychosocial and Palliative Care Program. They
are interested in assessing quality of life, including sexual functioning, in women with
and without a past history of breast cancer. In order to do so, they need to collect
information from women with a history of breast cancer, as well as women of the same
age without a history of breast cancer. Although sexual functioning is a sensitive topic, it
is an important concern for many breast cancer survivors. Only through research in this
area, will we be able to better assess and treat the concerns of breast cancer survivors.
Participation would entail completing a brief packet of questionnaires that takes
approximately 25 minutes to finish. The information you can provide will be important in
helping us better assess the types of changes women with breast cancer experience, so
that we might better plan for their care.
If you do not wish to learn more about this study, please call (813) 903-4606 or
1-800-456-3434 x4606 and you will not be contacted further. Otherwise, within the next
week, you will receive a phone call from Heidi Grenke in order to provide additional
information about how to participate in this study.
I greatly appreciate your taking the time to consider this request.
Sincerely,
Karen Fields, M.D.
Program Leader, Breast Program
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Appendix B: Telephone Script for Breast Cancer Participants
Hello, my name is Heidi Grenke and I am a graduate student at the University of South
Florida doing research at the Moffitt Cancer Center. Currently, I am doing a study along
with Dr. _________ and the other doctors in the Breast Program. Last week, you should
have received a letter from us describing a study we are currently doing on the quality of
life of women who have been diagnosed with cancer in the past 5 years.
Did you receive that letter?
Is now a good time to tell you a little bit more about the study?
We are most interested in finding out how you are feeling both physically and
emotionally now that treatment has ended and time has passed. If you agree to
participate, we will be asking for some of your time and input. We will be mailing you
out a questionnaire packet that will include questions about your mood, level of fatigue,
body image, and sexual functioning. This packet will take approximately 45 minutes to
complete. While some of the questions about sexual functioning will seem quite
personal, I want to guarantee you that all information will be kept strictly confidential.
The information you provide will help us to learn more about how to assist patients in
coping with possible side effect of cancer treatment over time.
We will also be asking you to nominate female friends within 5 years of your age that
would also be willing to complete a questionnaire for this study. We are asking women
without a breast cancer diagnosis to also complete the questionnaire so that we can
determine whether or not the quality of life of women treated for breast cancer differs
from that of the quality of life of women of similar age and circumstances NOT
diagnosed with breast cancer.
Does this sound like something you might be interested in?
I have a few questions to ask you, to ensure that this study is a good fit for you.
1.
2.
3.
4.

When were your first diagnosed with breast cancer? _____________
Have you seen your oncologist in the past year?
What did he/she say?
Have you ever been diagnosed with any other type of cancer (r/o if other than
basal cell)?
5. Do you have any other medical conditions that we should be aware of?
6. Do you have a spouse or partner with whom you are currently sexually active?

40

Appendix C: Recruitment Invitation for Non-Cancer Participants

Dear ___________________________,
I am taking part in a research study that looks at the impact of breast cancer treatment on quality
of life. This study is being done through the H. Lee Moffitt Cancer Center and Research Institute,
where I received my care, and focuses on sexual functioning in breast cancer survivors. One
important aspect of the study is to compare the reports of women who received breast cancer
treatment with those women without cancer (‘healthy controls’). This information will help the
researchers at Moffitt identify the specific needs of women treated for breast cancer.
I have nominated you to be invited to take part in this study as a ‘healthy control’. One of the
researchers at Moffitt, Heidi Grenke, will call you within the next week to further explain the
study. Taking part in this study would involve completing a questionnaire packet (which should
take about 25 minutes to complete) by mail on one occasion.
This type of research is needed so that doctors can improve their skills in helping women manage
the effects of breast cancer treatment and experience better quality of life. I encourage you to
take part in the study and I hope you will agree to participate.
Sincerely, _______________________________
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Appendix D: General Background Information Form for Breast Cancer Patients
We appreciate your participation in this project; we could not complete it without you.
Your answers will remain completely confidential. Thank you for your time.

/

/
/

1.

Today's date:

2.

Your birth date:

3.

Height

4.

Weight

5.

Which of the following best describes your ethnic background?

/
(ft)

(month/day/year)
(month/day/year)

(in)
(pounds)

1 Spanish/Hispanic/Latino
2 Not Spanish/Hispanic/Latino
6.

What is your race? (check one box)
1 White/Caucasian
2 Black/African American
3 Asian/Pacific Islander

7.

4 American Indian/Alaska Native
5 Other: ______________

What is the highest grade or level of education you have completed? (check one
box)
1 8th grade or less
2 Some high school (grade 9 to 12)
3 High school graduate or GED

8.

4 Vocational school or some college
5 College or university graduate
6 Professional or graduate school

What category best describes your usual occupation? If you are not currently
employed, which category best describes your LAST job? (check one box)
1
2
3
4
5
6
7

Professional (e.g., teacher/professor, nurse, lawyer, physician, engineer)
Manager/Administrator (e.g., sales managers)
Clerical (e.g., secretaries, clerks, or mail carriers)
Sales (e.g., sales persons, agents, and brokers)
Service (e.g., police, cooks, waitress, or hairdressers)
Skilled Crafts, Repairer (e.g., carpenters)
Equipment or Vehicle Operator (e.g., truck drivers)
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Appendix D: General Background Information Form for Breast Cancer Patients
(Continued)
8 Laborer (e.g., maintenance factory workers)
9 Farmer (e.g., owners, managers, operators, or tenants)
10 Member of the military
11 Homemaker (with no job outside the home)
12 Other (please describe)______________________________________

9.

Which category best describes your spouse/partner’s usual occupation? If your
spouse/partner is notcurrently employed, which category best describes his/her
LAST job? (check one box)
1 Professional (e.g., teacher/professor, nurse, lawyer, physician,engineer)
2 Manager/Administrator (e.g., sales managers)
3 Clerical (e.g., secretaries, clerks, or mail carriers)
4 Sales (e.g., sales persons, agents, and brokers)
5 Service (e.g., police, cooks, waitress, or hairdressers)
6 Skilled Crafts, Repairer (e.g., carpenters)
7 Equipment or Vehicle Operator (e.g., truck drivers)
8 Laborer (e.g., maintenance factory workers)
9 Farmer (e.g., owners, managers, operators, or tenants)
10 Member of the military
11 Homemaker (with no job outside the home)
12 Other (please describe)_________________________________________

10.

Which of the following best describes your current employment situation? (check
one box)
1
2
3
4
5
6
7

11.

Paid full-time employment
Paid part-time employment
Self-employed
On leave with pay
On leave without pay
Not employed - disabled
Not employed – retired

8 Student full-time
9 Student part-time
10 Homemaker
11 Volunteer
12 Unemployed-looking for work
13 Unemployed-not looking for work

What is your approximate annual gross income? (check one box)
1 Less than $ 10,000
4 $40,000 - $74,999
2 $10,000 - $19,999
5 $75,000 or more
3 $20,000 - $ 39,999
6 Prefer not to answer
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Appendix D: General Background Information Form for Breast Cancer Patients
(Continued)
12.

What was your total household income (from all sources) before taxes in the last
calendar year? Your answer will remain completely confidential. (check one
box)
1 Less than $ 10,000
2 $10,000 - $19,999
3 $20,000 - $ 39,999

13.

When were you first diagnosed with breast cancer?

/
14.

4 $40,000 - $74,999
5 $75,000 or more
6 Prefer not to answer

(month/year)

Which of the following have you received? (check all that apply)
1 Lumpectomy to remove the cancer
2 Mastectomy to remove the cancer
3 Lumpectomy + mastectomy to remove the cancer
4 Bilateral Mastectomy to remove the cancer
5 Breast reconstruction
6 Radiation therapy
7 Chemotherapy before your breast cancer surgery
8 Chemotherapy after your breast cancer surgery
9 Hormonal therapy to shrink or reduce the cancer (ex: Tamoxifen)
10 Hormonal therapy to prevent another cancer (ex: Tamoxifen)
11 Other (describe______________________________________)

15.

When did you finish chemotherapy treatments?
1

I did not receive chemotherapy treatment.

2

I finished chemotherapy treatments on

/
(month/year)

16.

When did you finish radiation treatments?
1

I did not receive radiation treatment.

2

I finished radiation treatments on

/
(month/year)
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Appendix D: General Background Information Form for Breast Cancer Patients
(Continued)
17.

Which of the following best describes how you presently function? (check one
box)
1 I am able to carry on normal activity or do work and I have no
physical complaints or problems.
2 I am able to carry on normal activity or do work even with minor
physical complaints.
3 I am able to carry on normal activity or do work but it takes effort
because of physical problems.
4 I am unable to carry on normal activity but I care for myself.
5 I am unable to carry on normal activity and I require occasional help
from others, but I am able to care for most of my personal needs.
6 I require considerable help from others and I require frequent
medical care.
7 I am disabled and I require special care and help.

18.

Do you take prescription medication regularly?
1 Yes
2 No

19.

Are you currently taking Tamoxifen?
1 Yes
2 No
If yes:
Dose:

Since:

________________________________ ______________________________
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Appendix D: General Background Information Form for Breast Cancer Patients
(Continued)
20.

21.

What medications, other than Tamoxifen, do you currently take?
Drug:

Dose:

______________

____________

________

__________________

______________

____________

________

__________________

______________

____________

________

__________________

______________

____________

________

__________________

Heterosexual
Homosexual
Bisexual
Prefer not to answer

What is your current marital status? (check one box)
1 Single, never married
2 Married
3 Living in a marriage-like relationship

23.

4 Divorced
5 Widowed
6 Separated

Length of time you have been with your current partner (check one box):
1 Less than 6 months
2 Six months to 1 year
3 One to 2 years

24.

Reason:

Please indicate your sexual orientation (check one box).
1
2
3
4

22.

Since:

4 Two to 5 years
5 More than 5 years

Were you with this current partner before your breast cancer diagnosis?
1 Yes
2 No

25.

Does your partner have any difficulty with sexual desire, becoming sexually
aroused, or achieving orgasm?
1 Yes (Go to question 26)
2 No (Go to question 27)
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Appendix D: General Background Information Form for Breast Cancer Patients
(Continued)
26.

When did your partner start having difficulties with sexual desire, becoming
sexually aroused, or achieving orgasm?

/
27.

(month/year)

Prior to your breast cancer diagnosis, did you have any difficulties with sexual
desire, becoming sexually aroused, or achieving orgasm?
1 Yes (Go to question 28)
2 No (Go to question 29)

28.

When did you start having difficulties with sexual desire, becoming sexually
aroused, or achieving orgasm?

/
29.

Current living arrangement (check one box):
1
2
3
4

30.

(month/year)

Live alone
5 Live with roommate who is not partner
Live with spouse/partner
6 Live with parents
Live with spouse/partner and children
7 Other (specify:__________)
Live with children (no spouse/partner)

How long in current living arrangement (check one box):
1 Less than 1 month
2 One to 6 months
3 Seven months to 2 years

31.

4 Between 2 to 5 years
5 More than 5 years

Number of children under 18 living at home:
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Appendix E: General Background Information Form for Non-Cancer Participants
We appreciate your participation in this project; we could not complete it without you.
Your answers will remain completely confidential. Thank you for your time.

/

/
/

1.

Today's date:

2.

Your birth date:

3.

Height

4.

Weight

5.

Which of the following best describes your ethnic background?

/
(ft)

(month/day/year)
(month/day/year)

(in)
(pounds)

1 Spanish/Hispanic/Latino
2 Not Spanish/Hispanic/Latino
6.

What is your race? (check one box)
1 White/Caucasian
2 Black/African American
3 Asian/Pacific Islander

7.

4 American Indian/Alaska Native
5 Other: _________________________

What is the highest grade or level of education you have completed? (check one
box)
1 8th grade or less
2 Some high school (grade 9 -12)
3 High school graduate or GED
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4 Vocational school or some college
5 College or university grad
6 Professional or graduate school

Appendix E: General Background Information Form for Non-Cancer Participants
(Continued)
8.

What category best describes your usual occupation? If you are not currently
employed, which category best describes your LAST job? (check one box)
1 Professional (e.g., teacher/professor, nurses, lawyer, physician, engineer)
2 Manager/Administrator (e.g., sales managers)
3 Clerical (e.g., secretaries, clerks, or mail carriers)
4 Sales (e.g., sales persons, agents, and brokers)
5 Service (e.g., police, cooks, waitress, or hairdressers)
6 Skilled Crafts, Repairer (e.g., carpenters)
7 Equipment or Vehicle Operator (e.g., truck drivers)
8 Laborer (e.g., maintenance factory workers)
9 Farmer (e.g., owners, managers, operators, or tenants)
10 Member of the military
11 Homemaker (with no job outside the home)
12 Other (please describe)________________________________________

9.

Which category best describes your spouse/partner’s usual occupation? If your
spouse/partner is not currently employed, which category best describes his/her
LAST job? (check one box)
1 Professional (e.g., teacher/professor, nurse, lawyer, physician, engineer)
2 Manager/Administrator (e.g., sales managers)
3 Clerical (e.g., secretaries, clerks, or mail carriers)
4 Sales (e.g., sales persons, agents, and brokers)
5 Service (e.g., police, cooks, waitress, or hairdressers)
6 Skilled Crafts, Repairer (e.g., carpenters)
7 Equipment or Vehicle Operator (e.g., truck drivers)
8 Laborer (e.g., maintenance factory workers)
9 Farmer (e.g., owners, managers, operators, or tenants)
10 Member of the military
11 Homemaker (with no job outside the home)
12 Other (please describe)_______________________________________

10.

Which of the following best describes your current employment situation? (check
one box)
1
2
3
4
5
6
7

Paid full-time employment
Paid part-time employment
Self-employed
On leave with pay
On leave without pay
Not employed - disabled
Not employed – retired

8 Student full-time
9 Student part-time
10 Homemaker
11 Volunteer
12 Unemployed-looking for work
13 Unemployed-not looking for work
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Appendix E: General Background Information Form for Non-Cancer Participants
(Continued)
11.

What is your approximate annual gross income? (check one box)
1 Less than $ 10,000
4 $40,000 - $74,999
2 $10,000 - $19,999
5 $75,000 or more
3 $20,000 - $ 39,999
6 Prefer not to answer

12.

What was your total household income (from all sources) before taxes in the last
calendar year? (check one box)
1 Less than $ 10,000
2 $10,000 - $19,999
3 $20,000 - $ 39,999

13.

4 $40,000 - $74,999
5 $75,000 or more
6 Prefer not to answer

Which of the following best describes how you presently function? (check one
box)
1 I am able to carry on normal activity or do work and I have no
physical complaints or problems.
2 I am able to carry on normal activity or do work even with minor
physical complaints.
3 I am able to carry on normal activity or do work but it takes effort
because of physical problems.
4 I am unable to carry on normal activity but I care for myself.
5 I am unable to carry on normal activity and I require occasional help
from others, but I am able to care for most of my personal needs.
6 I require considerable help from others and I require frequent
medical care.
7 I am disabled and I require special care and help.

14.

Do you take prescription medication regularly?
1 Yes (Go to question 15)
2 No (Go to question 16)
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Appendix E: General Background Information Form for Non-Cancer Participants
(Continued)
15.

16.

What medications do you currently take?
Drug:

Dose:

______________

____________

________

__________________

______________

____________

________

__________________

______________

____________

________

__________________

Heterosexual
Homosexual
Bisexual
Prefer not to answer

What is your current marital status? (check one box)
1 Single, never married
2 Married
3 Living in a marriage-like relationship

18.

4 Divorced
5 Widowed
6 Separated

Length of time you have been with your current partner (check one box):
1 Less than 6 months
2 Six months to 1 year
3 One to 2 years

19.

Reason:

Please indicate your sexual orientation. (check one box)
1
2
3
4

17.

Since:

4 Two to 5 years
5 More than 5 years

Does your partner have difficulties with sexual desire, becoming sexually
aroused, or achieving orgasm?
1 Yes (Go to question 20)
2 No (Go to question 21)

20.

When did your partner start having difficulties with sexual desire, becoming
sexually aroused, or achieving orgasm?

/

(month/year)
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Appendix E: General Background Information Form for Non-Cancer Participants
(Continued)
21.

Do you have any difficulties with sexual desire, becoming sexually aroused, or
achieving orgasm?
1 Yes (Go to question 22)
2 No (Go to question 23)

22.

When did you start having difficulties with sexual desire, becoming sexually
aroused, or achieving orgasm?

/
23.

Current living arrangement (check one box):
1
2
3
4

24.

(month/year)

Live alone
5 Live with roommate who is not partner
Live with spouse/partner
6 Live with parents
Live with spouse/partner and children
7 Other (specify:__________)
Live with children (no spouse/partner)

How long in current living arrangement (check one box):
1 Less than 1 month
2 One to 6 months
3 Seven months to 2 years

25.

4 Between 2 to 5 years
5 More than 5 years

Number of children under 18 living at home:

52

Appendix F: Center for Epidemiologic Studies, Depression Scale
For each statement below, make an “X” in the box which best describes how often you
felt or behaved this way-- DURING THE PAST WEEK, INCLUDING TODAY.
None of A Little of
the Time the Time
DURING THE PAST WEEK:
1.
I was bothered by things that
usually don't bother me
2.
I did not feel like eating; my
appetite was poor.
3.
I felt that I could not shake off the
blues even with help from my
family or friends
4.
I felt that I was just as good as
other people
5.
I had trouble keeping my mind on
what I was doing
6.
I felt depressed
7.
I felt that everything I did was
an effort
8.
I felt hopeful about the future
9.
I thought my life had been a failure
10. I felt fearful
11. My sleep was restless
12. I was happy
13. I talked less than usual
14. I felt lonely
15. People were unfriendly
16. I enjoyed life
17. I had crying spells
18. I felt sad
19. I felt that people disliked me
20. I could not “get going”

.........
.........
.........
.........
.........
.........
.........
.........
.........
.........
.........
.........
.........
.........
.........
.........
.........
.........
.........
.........
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A Moderate Most
Amount of of the
Time
Time

Appendix G: Fatigue Symptom Inventory
For each of the following, circle the one number that best indicates how that item applies
to you.
1. Rate your level of fatigue on the day you felt most fatigued during the past week.
0
1
2
3
4
5
6
7
8
9
10
Not at all
As fatigued
fatigued
as I could be
2. Rate your level of fatigue on the day you felt least fatigued during the past week.
0
1
2
3
4
5
6
7
8
9
10
Not at all
As fatigued
fatigued
as I could be
3. Rate your level of fatigue on the average in the last week.
0
1
2
3
4
5
6
7
Not at all
fatigued
4. Rate your level of fatigue right now.
0
1
2
3
4
Not at all
fatigued

5

6

7

8

9
10
As fatigued
as I could be

8

9
10
As fatigued
as I could be

5. Rate how much, in the past week, fatigue interfered with your general level of
activity:
0
1
2
3
4
5
6
7
8
9
10
No
Extreme
interference
interference
6. Rate how much, in the past week, fatigue interfered with your ability to bathe and
dress yourself:
0
1
2
3
4
5
6
7
8
9
10
No
Extreme
interference
interference
7. Rate how much, in the past week, fatigue interfered with your normal work activity
(includes both work outside the home and housework):
0
1
2
3
4
5
6
7
8
9
10
No
Extreme
interference
interference
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Appendix G: Fatigue Symptom Inventory (Continued)
8. Rate how much, in the past week, fatigue interfered with your ability to concentrate
0
1
2
3
4
5
6
7
8
9
10
No
Extreme
interference
interference
9. Rate how much, in the past week, fatigue interfered with your relations with other
people:
0
1
2
3
4
5
6
7
8
9
10
No
Extreme
interference
interference
10. Rate how much, in the past week, fatigue interfered with your enjoyment of life:
0
1
2
3
4
5
6
7
8
9
10
No
Extreme
interference
interference
11. Rate how much, in the past week, fatigue interfered with your mood:
0
1
2
3
4
5
6
7
8
9
10
No
Extreme
12. Indicate how many days, in the past week, you felt fatigued for any part of the day:
0
1
2
3
4
5
6
7
Days
Days
13. Rate how much of the day, on average, you felt fatigued in the past week:
0
1
2
3
4
5
6
7
8
9
10
None of
The entire
the day
day
14. Indicate which of the following best describes the daily pattern of your fatigue in the
past week:
0
1
2
3
4
Not at all
Worse in Worse in the Worse in
No consistent daily
fatigued
the morning afternoon the evening
pattern of fatigue
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Appendix H: Body Exposure in Sexual Activities Questionnaire
If you have not engaged in sexual activity in the last six months, please mark
an “X” in this box
and proceed on to the next questionnaire.
We are interested in the thoughts and behaviors that an individual may experience
or enact during sexual encounters. Read each statement carefully and identify how
characteristic it is of you and your experience using the following code:
Never
1. During sexual activity I am constantly
thinking that my partner will notice
something about my body that is a
turnoff……….
2. During sexual activity I worry that my
partner will find aspects of my physique
unappealing……………….
3. During sexual activity I am aware of
how my body looks…………………
4. During sexual activity something about
the way my body looks makes me feel
inhibited……………………….
5. I am uncomfortable when undressed by
my partner……
6. I prefer to keep my body hidden under
a sheet or blanket during sexual activity…
7. I am comfortable with my partner
looking at my genitals during sexual
activity……………………………..
8. During sexual activity I worry that my
partner will find my body repulsive……
9. During sexual activity I worry that my
partner will think the size and shape of my
sex organs are in-adequate or unattractive
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Appendix H: Body Exposure in Sexual Activities Questionnaire (Continued)
Never
10. When it comes to my partner seeing me
naked, I have nothing to hide…………
11. During sexual activity I have thoughts
that my body looks sexy……
12. I don’t like my partner to see me
completely naked during sexual activity…
13. During sexual activity I expect my
partner to be excited by seeing me
without my clothes……………………
14. I prefer to keep certain articles of clothing
on during sexual activity………………
15. I am self-conscious about my body during
sexual activity…………………………….
16. During sexual activity I worry that my
partner will find the appearance or odor of
my genitals repulsive …..
17. During sexual activity I try to hide certain
areas of my body from my partner’s view…
18. During sexual activity I keep thinking
that parts of my body are too
unattractive to be sexy………………….
19. There are parts of my body that I don’t
want my partner to see during sexual
activity………………………
20. During sexual activity I worry about
what my partner thinks about how my
body looks……………………..
21. During sexual activity I worry that my
partner could be turned off by the way
parts of my body feel to his/her touch…
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Appendix H: Body Exposure in Sexual Activities Questionnaire (Continued)
Never
22. During sexual activity it is hard for me
not to think about my weight……
23. I feel self-conscious if the room is
too well lit during sexual activity
24. I am generally comfortable having
parts of my body exposed to my\
partner during sexual activity…………….
25. During sexual activity I enjoy having
my partner look at my body……………
26. During sexual activity there are certain
poses or positions I avoid because of
the way my body would look to my
partner …
27. During sexual activity I am distracted
by thoughts of how certain parts of my
body look………………………..
28. I am comfortable with my partner
looking at my breast area during sexual
activity…….……………………………
29. During sexual activity I worry that my
partner will find my breast area repulsive
30. During sexual activity I worry that my
partner will think the size and shape of
my breasts are inadequate or unattractive
31. During sexual activity I worry about what
my partner thinks about how my breast
area looks………………….
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Appendix I: The Body-Self Relations Questionnaire: Appearance Evaluation Subscale
Using the scale below, please check one box that best matches your agreement with the
following statements.
Definitely
Disagree
1.
2.
3.
4.
5.
6.
7.

Mostly
Disagree

Neither
Agree nor
Disagree

Mostly
Agree

Definitely
Agree

My body is sexually
appealing………..
I like my looks just
the way they are….
Most people would
consider me good
looking……………
I like the way I look
Without my clothes
I like the way my
clothes fit me……….
I dislike my
physique…
I’m physically
unattractive.…

Would you be interested in receiving a free copy of the American Cancer Society booklet
entitled, “Sexuality and Cancer: For the Woman Who Has Cancer, and
Her Partner”?
Yes

No
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Appendix J: Dyadic Adjustment Scale
Most persons have disagreements in their relationships. Please indicate below the approximate extent of
agreement or disagreement between you and your partner for
each item on the following list.
Always
Agree

Almost
Always
Agree

All
the time

Most of
the time

Occasionally
Disagree

Frequently
Disagree

Almost
Always
Disagree

Always
Disagree

Rarely

Never

1. Demonstrations
of affection
2. Sex relations
More
often
than not

3. How often do
you discuss or have
you considered
divorce, separation,
or terminating
your relationship?
4. How often do
you or your mate
leave the house after
a fight?
5. In general, how
often do you think
that things between
you and your partner
are going well?
6. Do you confide in
your mate?………
7. Do you everregret
that you married?
(or lived together).
8. How often do
you and your
partner quarrel?
9. How often do you
and your mate
“get on each
other’s nerves?”
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Occasionally

Appendix J: Dyadic Adjustment Scale (Continued)
Almost
Every Day

Every Day

Occasionally

Rarely

Never

10. Do you kiss your
mate?…...

There are some things about which couples sometimes agree and sometime disagree.
Indicate if either item below caused differences of opinions or were problems in your
relationship during the past few weeks. (Mark an “X” in the box.)
Yes

No

11. Being too tired for sex
12. Not showing love
13. The descriptors on the following line represent different degrees of happiness in your
relationship. The middle point, “happy,” represents the degree of happiness of most
relationships. Please circle the descriptor that best describes the degree of happiness, all
things considered, of your relationship.
Extremely
Unhappy

Fairly
Unhappy

A Little
Unhappy

Happy

Very
Happy

Extremely
Happy

Perfect

14. Which of the following statements best describes how you feel about the future of
your relationship? (Check one box.)
I want desperately for my relationship to succeed, and would go to almost any
length to see that it does.
I want very much for my relationship to succeed, and will do all I can to see that
it does.
I want very much for my relationship to succeed, and will do my fair share to see
that it does.
It would be nice if my relationship succeeded, but I can’t do much more than I am
doing now to help it succeed.
It would be nice if it succeeded, but I refuse to do any more than I am doing now
to keep the relationship going.
My relationship can never succeed, and there is no more that I can do to keep the
relationship going.
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Appendix K: The Breast Cancer Prevention Trial Symptom Checklist
We are interested in knowing whether you have had any of the following problems
during the PAST FOUR WEEKS.
Not at
all

Slightly

1. Hot flashes………
2. Headaches………
3. Blind spots, fuzzy
vision…………...
4. Nausea……………
5. Vomiting………….
6. Diarrhea………….
7. Constipation………
8. Difficulty with bladder
control (when laughing
or crying)………….
9. Difficulty with bladder
control (at other
times)……………
10. Vaginal discharge……
11. Vaginal bleeding or
spotting………
12. Genital
itching/irritation…
13. Vaginal dryness……
14. Pain with
intercourse……………
15. Cramps…………………
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Moderately

Quite a bit

Extremely

Appendix K: The Breast Cancer Prevention Trial Symptom Checklist (Continued)
Not at
all

Slightly

Moderately

Quite a bit

Extremely

Slightly

Moderately

Quite a bit

Extremely

16. Breast
sensitivity/tenderness…
17. Ringing in ears…………
18. General aches and pains..
19. Joint pains………………
20. Chest pains……………
21. Swelling of hands or
feet..
Not at
all

22. Muscle stiffness………
23. Difficulty breathing……
24. Dry mouth……………
25. Weight gain……………
26. Weight loss……………
27. Unhappy with the
appearance of my body..
28. Decreased appetite……
29. Feelings of suffocation…
30. Forgetfulness…………
31. Excitability……………
32. Short temper……………
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Appendix K: The Breast Cancer Prevention Trial Symptom Checklist (Continued)
Not at
all

Slightly

33. Tendency to take naps;
stay in bed………………
34. Night sweats……………
35. Cold sweats……………
36. Tendency toward
accidents……….
37. Avoidance of social
affairs………..
38. Difficulty concentrating..
39. Easily distracted………
40. Dizziness, faintness……
41. Numbness, tingling……
42. Early awakening………
43. Any other problems?
(Please specify.)_______
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Moderately

Quite a bit

Extremely

Appendix L: Sexual Functioning Questionnaire
These next questions are sensitive and personal. They are very important in understanding
how your medical illness or treatment affects your self and your body. Some questions ask
about your own experiences, thoughts, and feelings, while others ask about how treatment
has affected your intimate relationships. Please answer each question honestly and
accurately. Be assured that your responses are totally confidential.
1.

In the PAST MONTH, how frequently have you had sexual thoughts, urges,
fantasies, or erotic dreams? (Please make an “X” in the one box that is closest to your
experience.)
Not at all
Once
2 or 3 times
Once a week
2 or 3 times per week
Once a day
More than once a day

2. Using the scale below, how frequently have you felt an interest or desire to engage in
the following specific activities in the PAST MONTH? (This question is about your
interest and desires, not about how often you have engaged in sexual activity. For each
item, please make an “X” in the one box that is closest to your experience):
Not
at
all

Once

2 to 3
times

a Dreams or fantasy
b Masturbation
c Touching,
hugging, holding,
kissing
d Petting and
foreplay
e Vaginal
intercourse
f Other sexual
activity please
specify:
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Once
a
week

2 to 3
times
per wk

Once
a
Day

More
than
once
a day

Appendix L: Sexual Functioning Questionnaire (Continued)
3. Using the scale below, how frequently have you become aroused by the following
sexual activity in the PAST MONTH? (By arousal, we mean the physical and
emotional responses in your body and mind that tell you that you are feeling sexual.
This question is about your arousal, not about how often you have engaged in sexual
activity):

Not
at
all

Once

2
to
3
times

Once
a
week

2
to
3
times
per
week

Once
a
day

More
than
once
a day

a Dreams or fantasy
b Masturbation
c Touching, hugging,
holding, kissing
d Petting and
foreplay
e Vaginal
intercourse.
f Other sexual
activity please
specify:
________________
4. In the PAST MONTH, have you felt pleasure from any sexual activity? (Please mark
one box.)
1
2
3
4
5
6

I have had no sexual activity in the past month
I have not felt any pleasure
Seldom, less than 25% of the time
Sometimes, about 50% of the time
Usually, about 75% of the time
Always felt pleasure
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Appendix L: Sexual Functioning Questionnaire (Continued)
5. Using the scale below, how frequently have you engaged in the following sexual
activity in the PAST MONTH?

Not at
all

2 to 3
times

Once

Once a
week

2
to
3
times
per
week

Once
a
day

More
than
once
a day

a Dreams or fantasy
b Masturbation
c Touching, hugging,
holding, kissing
d Petting and
foreplay
e Vaginal
intercourse.
f Other sexual
activity please
specify:
________________
6. In the PAST MONTH, how often have you reached orgasm (climax) during sexual
activity? (Please mark one box.)
1
2
3
4
5
6

I have had no sexual activity in the past month
I have not experienced orgasm
Seldom, less than 25% of the time
Sometimes, about 50% of the time
Usually, about 75% of the time
I always experienced orgasm

7. When you have orgasms (climax), how intense have they been in the PAST MONTH?
1
2
3
4
5
6

I have had no sexual activity in the past month
I have had no orgasms in the last month
My orgasms were very mild
My orgasms were fairly mild
My orgasms were fairly strong
My orgasms were very strong
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Appendix L: Sexual Functioning Questionnaire (Continued)
8. How easy or difficult has it been for you to have orgasms (climax) in the PAST
MONTH?
1 I have had no sexual activity in the past month
2 I have had no orgasms in the last month
3 It was very difficult to have orgasms; it took a long time and a lot of
concentration
4 It was fairly difficult; it took a while
5 It was fairly easy
6 It was very easy
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Appendix L: Sexual Functioning Questionnaire (Continued)
How frequently in the PAST MONTH have you had the problems listed below?
all”,
activity?

Not at all

Seldom,
less than
25% of the
time

If you have checked anything other than “not at
has it stopped or reduced your sexual
Sometimes
Less than
50% of the
time

Usually,
about 75%
of the time
Always

Yes

a.

Problems with dreams or fantasies………..

……………

b.

Problems with masturbation………………

……………

c.

Problems with touching, hugging, holding,
kissing…………………………………………

……………

Problems with petting and
foreplay…………………….………………….

……………

Problems with vaginal
intercourse……………………………………

……………

Problems with other sexual activity
Please specify: _________________

……………

Vaginal bleeding or irritation after penetration
or intercourse…………………..

……………

d.
e.
f.
g.
h.

Sharp pain inside or outside your vagina…

i.

Increased sensitivity of your skin to intimate
touching…………………………….

……………

Other problem with sexuality
Please specify: _________________

……………

j.

……………
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Appendix L: Sexual Functioning Questionnaire (Continued)
10. Please rate how interested you have been in sexual thoughts, feelings, or actions in the PAST
MONTH by circling a number from 0 to 10.

0
1
Not at all
Interested

2

3

4

5

6

7

8

9

10
Extremely
Interested

11. Please rate the extent to which sexual activity has been satisfying for you in the PAST
MONTH by circling a number from 0 to 10.

0
1
Not at all
Interested

2

3

4

5

6

7

8

9

10
Extremely
Interested

12. How often did the following factors influence your sexual activity in the PAST MONTH?

Not
at
all

Seldom,
less
than 25%
of the
time

Sometimes,
about
50%
of
the time

Usually,
about
75%
of
the time

Always

a My own health
b My partner’s health
c Conflict in my relationship
d Other please specify:
_____________________

13. How frequently have you been able to communicate your sexual desires or preferences to your
partner in the PAST MONTH?
1
2
3
4
5
6

I have not had a partner
I was always able to communicate my desires or preferences
Usually, about 75% of the time
Sometimes, about 50% of the time
Seldom, less than 25% of the time
I have been unable to communicate my desires or preferences
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Appendix L: Sexual Functioning Questionnaire (Continued)
14. Overall, how satisfied have you been with your sexual relationship with your partner?
1
2
3
4
5

Very satisfied
Somewhat satisfied
Neither satisfied nor dissatisfied
Somewhat dissatisfied
Very dissatisfied

15. Overall, how satisfied do you think your partner has been with your sexual
relationship?
1
2
3
4
5

Very satisfied
Somewhat satisfied
Neither satisfied nor dissatisfied
Somewhat dissatisfied
Very dissatisfied

16. Please rate how satisfied you have been with your ability to share warmth and
intimacy with your partner in the PAST MONTH by circling the number below from 0
to 10.
0
1
Not at all
Satisfied

2

3

4

5

6

7

8

9

10
Extremely
Satisfied

17.
Please rate how comfortable you are with touching, hugging or holding your
partner in the PAST MONTH by circling the number below from 0 to 10.
0
1
2
Not at all
Comfortable

3

4

5

6

7

8

9

10
Extremely
Comfortable

18.
Please rate how well you think you have adjusted to changes in your sex life since
your breast cancer diagnosis by circling a number from 0 to 10.
0
1
Not at all
Well

2

3

4

5

6
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7

8

9

10
Extremely
Well

Appendix L: Sexual Functioning Questionnaire (Continued)
19. What impact has your breast cancer and its treatment had on your sex life?
1
2
3
4
5

My sex life is a lot better than before
My sex life is a little better than before
My sex life is no different than before
My sex life is a little worse than before
My sex life is a lot worse than before

20. What impact has your breast cancer and its treatment had on your interest or desire
for sex? (This question is about your thoughts, fantasies or wishes, not about how you
feel during sexual activity.)
1
2
3
4
5
6

My interest is stronger
My interest is about the same
My interest is a little less
My interest is somewhat less
My interest is a lot less
I have lost all of my interest

21. What impact has your breast cancer and its treatment had on your sexual arousal
during sexual activity? (By arousal, we mean the physical and emotional responses
in your body and mind that tell you that you are feeling sexual.)
1
2
3
4
5
6

I am aroused more easily than ever
Arousal is about the same
It takes longer to get aroused, but the level of arousal is about the same
It takes longer to get aroused, and the level of arousal is not as intense
It is quite a bit more difficult for me to get aroused
I do not seem able to get aroused al all
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Appendix L: Sexual Functioning Questionnaire (Continued)
22. What impact has your breast cancer and its treatment had on your orgasms during
sex?
1
2
3
4

They are stronger than ever
They are about the same
It takes longer to get orgasm, but the intensity is about the same
It takes longer to get orgasm, and they are less intense than before the
illness and treatment
5 Since the treatment, I am unable to orgasm
6 I have never experienced orgasm

23. Is there anything you would like to add about how sex has changed for you since
your breast cancer and its treatment? Please describe below, as well as on the back
of this sheet.
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